Efficacy and safety of remimazolam compared with propofol in hypertensive patients undergoing breast cancer surgery: a single-center, randomized, controlled study
Yaqi Huang, Ting Yan, Guiting Lu, Huirong Luo, Zhongmeng Lai, Liangcheng Zhang · 2023
Read Efficacy and safety of remimazolam compared with propofol in hypertensive patients undergoing breast cancer surgery: a single-center, randomized, controlled study by Yaqi Huang, Ting Yan, Guiting Lu, Huirong Luo, Zhongmeng Lai, Liangcheng Zhang (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10714447.txt.
Description
Yaqi Huang and five co-authors compared two anesthetics in patients with high blood pressure having breast cancer surgery, in a 2023 trial. One drug is a newer agent reported to keep blood pressure steadier. The other is the long-standard choice. One hundred twenty patients were assigned by chance to one drug or the other. Care was otherwise the same in both groups.
Dangerous pressure drops after induction were the main outcome. They occurred less often with the newer drug. The lowest pressure during induction also stayed higher in that group. Other outcomes, including drug use for pressure support and next-day recovery scores, did not differ. Side effects were similar between groups. The authors conclude the newer drug is safe in this group. It may give steadier blood pressure at induction than the standard drug.
Catalog record
| CREATOR | Yaqi Huang, Ting Yan, Guiting Lu, Huirong Luo, Zhongmeng Lai, Liangcheng Zhang |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |